Health Care & Life Sciences » Biotechnology | Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. | Key People and Executives

Richard M. Glickman
Chairman & Chief Executive Officer
Michael R. Hayden
Director
Joseph P. Hagan
Director
George M. Milne
Director
Lorin Jeffry Randall
Lead Independent Director
David R. W. Jaynee
Independent Director
Hyuek Joon Lee
Independent Director
Benjamin Rovinski
Independent Director
Richard M. Glickman
Chairman & Chief Executive Officer
Michael R. Martin
Chief Operating Officer
Dennis Bourgeault
Chief Financial Officer
Rashieda Gluck
Senior Vice President-Global Clinical Operations
Simrat Randhawa
Head-Medical Affairs
Neil Solomons
Chief Medical Officer
Bradley J. Dickerson
General Manager
Robert B. Huizinga
Executive Vice President-Corporate Development
Erik Eglite
Chief Compliance Officer, SVP & General Counsel
Lawrence D. Mandt
Vice President-Regulatory Affairs & Quality
Michael R. Hayden
Director
Joseph P. Hagan
Director
George M. Milne
Director
Lorin Jeffry Randall
Director
Celia Economides
Vice President-Corporate & Public Affairs
David R. W. Jaynee
Independent Director
Hyuek Joon Lee
Independent Director
Benjamin Rovinski
Independent Director

About Aurinia Pharmaceuticals

View Profile
Address
4464 Markham Street
Victoria British Columbia V8Z 7X8
Canada
Employees -
Website http://www.auriniapharma.com
Updated 07/08/2019
Aurinia Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases particularly lupus nephritis. The company was founded by Robert Foster, Richard Glickman and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.